F.D.A. to Relabel Leucovorin for Autism Treatment

F.D.A. to Relabel Leucovorin for Autism Treatment

The F.D.A. announced Monday that it would change the drug’s label to reflect potential benefits in reducing autism symptoms. continue reading...

Author
The New York Times

You May Also Like